Loading clinical trials...
Loading clinical trials...
A Placebo-controlled, Double-blind Evaluation of Safety, Tolerability, and Efficacy of XT- 150 for the Treatment of Facet Joint Osteoarthritis Pain
Conditions
Interventions
XT-150
Placebo
Locations
3
United States
Neurovations
Napa, California, United States
Source HealthCare
Santa Monica, California, United States
Center for Clinical Research
Winston-Salem, North Carolina, United States
Start Date
February 24, 2022
Primary Completion Date
September 20, 2023
Completion Date
September 20, 2023
Last Updated
January 15, 2025
NCT00397280
NCT06200207
NCT04638647
NCT06661850
NCT03836248
NCT06750653
Lead Sponsor
Xalud Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions